Mild Cognitive Impairment – it’s not dementia, but it is just as important for pharmacists to know what it is and how to manage it.

August 2022 ･ 30 min watch

Link copied!

Key takeaways

In this webinar Associate Professor Michael Woodward discusses:

  • Mild Cognitive Impairment (MCI) and the changes that occur in individuals with MCI
  • The importance of early detection and process of diagnosis of MCI
  • The underlying causes of MCI, risk factors for progression and prevention strategies
  • Areas where pharmacists can make a real difference for patients and their families.

Mild Cognitive Impairment (MCI) currently affects around 1 million people in Australia. Having MCI doesn’t mean a person has dementia or even that they will go on to develop dementia, however early identification and management is critical to influence the trajectory for these patients. Pharmacists are ideally placed to identify patients with symptoms of mild cognitive impairment and to help implement healthcare strategies that can reverse, stabilise or slow the progression of this condition.

Speaker: Associate Professor Michael Woodward, Geriatrician & Director at Aged Care Research, Austin Health

Pharmacists can self-record Group 1 CPD credit for this webinar recording.

Was this helpful?
0 0